Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Cited by (902)

Items 401–500 of 902

1. Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014
   Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer · 2014 · Journal of Alzheimer s Disease
2. A seasonal switch in histone deacetylase gene expression in the hypothalamus and their capacity to modulate nuclear signaling pathways
   Patrick N. Stoney, Diana Rodrigues, Gisela Helfer, Thabat Khatib, Anna Ashton, Elizabeth A. Hay, Robert Starr, Dagmara Kociszewska, Peter J. Morgan, Peter J. A. McCaffery · 2016 · Brain Behavior and Immunity
3. Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6
   Yudibeth Sixto‐López, Martiniano Bello, José Correa‐Basurto · 2018 · Journal of Biomolecular Structure and Dynamics
4. Stabilization of primary cilia reduces abortive cell cycle re-entry to protect injured adult CNS neurons from apoptosis
   Brian Choi, Philippe M. D’Onofrio, Alireza P. Shabanzadeh, Paulo D. Koeberle · 2019 · PLoS ONE
5. Inhibition of HDAC6 by tubastatin A disrupts mouse oocyte meiosis via regulating histone modifications and mRNA expression
   Liyan Sui, Rong Huang, Hao Yu, Sheng Zhang, Ziyi Li · 2020 · Journal of Cellular Physiology
6. Ir-Catalyzed Asymmetric Tandem Allylation/Iso-Pictet–Spengler Cyclization Reaction for the Enantioselective Construction of Tetrahydro-γ-carbolines
   Fan Xiao, Shiming Xu, Xiu‐Qin Dong, Chun‐Jiang Wang · 2021 · Organic Letters
7. HDAC6 Inhibition Corrects Electrophysiological and Axonal Transport Deficits in a Human Stem Cell‐Based Model of Charcot‐Marie‐Tooth Disease (Type 2D)
   Alec S.T. Smith, Jong Hyun Kim, Changho Chun, Ava Gharai, Hyo Won Moon, Eun Young Kim, Soo Hyun Nam, Nina Ha, Ju Young Song, Ki Wha Chung et al. · 2021 · Advanced Biology
8. A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold
   Melissa M. Kemp, Qiu Wang, Jason H. Fuller, Nathan H. West, Nicole M. Martínez, Elizabeth M. Morse, Michel Weïwer, Stuart L. Schreiber, James E. Bradner, Angela N. Koehler · 2011 · Bioorganic & Medicinal Chemistry Letters
9. Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia
   Danielle M. Desjardins, Yueying Liu, Craig E. Crosson, Zsolt Ablonczy · 2016 · PLoS ONE
10. Role of histone deacetylase inhibitors in non-neoplastic diseases
    Chunxiao Zhou, Dengke Zhao, Chunyan Wu, Zhimin Wu, Wen Zhang, Shilv Chen, Xindong Zhao, Shao-Ling Wu · 2024 · Heliyon
11. Preclinical Evaluation of an 18F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain
    Tetsuro Tago, Jun Toyohara, Kenji Ishii · 2021 · ACS Chemical Neuroscience
12. Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology
    Simona Barone, Emilia Cassese, Antonella Ilenia Alfano, Margherita Brindisi, Vincenzo Summa · 2022 · Journal of Medicinal Chemistry
13. α-Tubulin detyrosination links the suppression of MCAK activity with taxol cytotoxicity
    Danilo Lopes, Alexandre L. Seabra, Bernardo Orr, Hélder Maiato · 2022 · The Journal of Cell Biology
14. Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity
    Fengling Liu, Chunxi Liu, Qipeng Chai, Chunlong Zhao, Hongwei Meng, Xue Xia, Tso‐Pang Yao, Yingjie Zhang · 2023 · Journal of Medicinal Chemistry
15. Tackling triple negative breast cancer with HDAC inhibitors: 6 is the isoform!
    Anna Guadagni, Simona Barone, Antonella Ilenia Alfano, Sveva Pelliccia, Ivana Bello, Elisabetta Panza, Vincenzo Summa, Margherita Brindisi · 2024 · European Journal of Medicinal Chemistry
16. Novel histone deacetylase 8 ligands without a zinc chelating group: Exploring an ‘upside-down’ binding pose
    Aditya Sudheer Vaidya, Raghupathi Neelarapu, Antonett Madriaga, He Bai, Emma L. Mendonca, Hazem Abdelkarim, Richard Bruce van Breemen, Sylvie Y. Blond, Pavel A. Petukhov · 2012 · Bioorganic & Medicinal Chemistry Letters
17. A Decade of the Human Genome Sequence—How Does the Medicinal Chemist Benefit?
    Andreas Brunschweiger, Jonathan Hall · 2011 · ChemMedChem
18. Phenylpyrrole-Based Hdac Inhibitors: Synthesis, Molecular Modeling and Biological Studies
    Margherita Brindisi, Caterina Cavella, Simone Brogi, Angela Nebbioso, Johanna Senger, Samuele Maramai, Alfonso Ciotta, Concetta Iside, Stefania Butini, Stefania Lamponi et al. · 2016 · Future Medicinal Chemistry
19. Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors
    D. Rajasekhar Reddy, Flavio Ballante, Nancy Zhou, Garland R. Marshall · 2016 · European Journal of Medicinal Chemistry
20. A Highly Potent and Selective Histone Deacetylase 6 Inhibitor Prevents DSS-Induced Colitis in Mice
    Ting Liu, Renping Wang, Haojie Xu, Yunlong Song, Yunpeng Qi · 2017 · Biological and Pharmaceutical Bulletin
21. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies
    Abdullahi İbrahim Uba, Kemal Yelekçi · 2018 · Computational Biology and Chemistry
22. Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6
    Abdullahi İbrahim Uba, Kemal Yelekçi · 2018 · Computational Biology and Chemistry
23. Regulation of Fibroblast Apoptosis and Proliferation by Micro RNA ‐125b in Systemic Sclerosis
    Anastasiia Kozlova, Elena Pachera, Britta Maurer, Astrid Jüngel, Jörg H. W. Distler, Gabriela Kania, Oliver Distler · 2019 · Arthritis & Rheumatology
24. X-ray Crystallographic Snapshots of Substrate Binding in the Active Site of Histone Deacetylase 10
    Corey J. Herbst‐Gervasoni, David W. Christianson · 2021 · Biochemistry
25. Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2)
    Taotao Feng, Hai Wang, Hong Lin Su, Hui Lu, Li‐Qin Yu, Xiaojin Zhang, Haopeng Sun, Qidong You · 2013 · Bioorganic & Medicinal Chemistry
26. Histone deacetylase 6 plays an important role in TGF-β-induced murine Treg cell differentiation by regulating cell proliferation
    Ji Hyeon Lee, Hyeong Su Kim, Sung Woong Jang, Gap Ryol Lee · 2022 · Scientific Reports
27. RETRACTED ARTICLE: Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma
    Xiaopeng Peng, Ziwen Yu, Goverdhan Surineni, Bulian Deng, Meizhu Zhang, Chuan Li, Zhiqiang Sun, Wanyi Pan, Yao Liu, Shenglan Liu et al. · 2023 · Journal of Enzyme Inhibition and Medicinal Chemistry · Retracted
28. Anticancer RuII and RhIII Piano‐Stool Complexes that are Histone Deacetylase Inhibitors
    Jasmine M. Cross, Tim R. Blower, Natalie Gallagher, Jason H. Gill, Kimberly L. Rockley, James W. Walton · 2016 · ChemPlusChem
29. Rescue of CAMDI deletion‐induced delayed radial migration and psychiatric behaviors by HDAC6 inhibitor
    Toshifumi Fukuda, Shun Nagashima, Takaya Abe, Hiroshi Kiyonari, Ryoko Inatome, Shigeru Yanagi · 2016 · EMBO Reports
30. Combined Ligand and Fragment‐based Drug Design of Selective Histone Deacetylase – 6 Inhibitors
    Dušan Ružić, Miloš Petković, Danica D. Agbaba, Arasu Ganesan, Katarina M. Nikolic · 2019 · Molecular Informatics
31. First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement**
    Daniel Herp, Johannes Ridinger, Dina Robaa, Stephen A. Shinsky, Karin Schmidtkunz, Talha Z. Yesiloglu, Theresa Bayer, Raphael R. Steimbach, Corey J. Herbst‐Gervasoni, Annika Merz et al. · 2022 · ChemBioChem
32. Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors
    Gibeom Nam, Jun Min Jung, Hyun‐Ju Park, Seung Yeop Baek, Ki Seon Baek, Hui yeon Mok, Da Eun Kim, Young Hoon Jung · 2019 · Bioorganic & Medicinal Chemistry
33. Design of Selective Histone Deacetylase Inhibitors: Rethinking Classical Pharmacophore
    Jelena Melesina, Lucas Praetorius, Conrad Veranso Simoben, Dina Robaa, Wolfgang Sippl · 2018 · Future Medicinal Chemistry
34. A selenium-containing selective histone deacetylase 6 inhibitor for targeted in vivo breast tumor imaging and therapy
    Chu Chi Tang, Yang Du, Qian Ying Liang, Zhen Cheng, Jie Tian · 2019 · Journal of Materials Chemistry B
35. HDAC6 Substrate Discovery Using Proteomics-Based Substrate Trapping: HDAC6 Deacetylates PRMT5 to Influence Methyltransferase Activity
    Inosha D. Gomes, Udana V. Ariyaratne, Mary Kay H. Pflum · 2021 · ACS Chemical Biology
36. Computer- and structure-based lead design for epigenetic targets
    Ralf Heinke, Luca Carlino, Srinivasaraghavan Kannan, Manfred Jung, Wolfgang Sippl · 2011 · Bioorganic & Medicinal Chemistry
37. Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity
    Jakyung Yoo, Sojin Kim, Dohyun Son, Heewon Seo, Seung Yeop Baek, Cheol-Young Maeng, Changsik Lee, In Su Kim, Young Hoon Jung, Sun‐Mee Lee et al. · 2016 · European Journal of Medicinal Chemistry
38. Synthesis of Structurally Diverse 2,3-Fused Indoles via Microwave-Assisted AgSbF6-Catalysed Intramolecular Difunctionalization of o-Alkynylanilines
    Yuanqiong Huang, Yan Yang, Hongjian Song, Yuxiu Liu, Qingmin Wang · 2015 · Scientific Reports
39. Recent Advances in Small Molecular Modulators Targeting Histone Deacetylase 6
    Yufeng Xiao, Xuan Zhang · 2020 · Future Drug Discovery
40. Profiling of Substrates for Zinc‐dependent Lysine Deacylase Enzymes: HDAC3 Exhibits Decrotonylase Activity In Vitro
    Andreas S. Madsen, Christian Adam Olsen · 2012 · Angewandte Chemie
41. The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentials
    Chengcheng Huang, Yuxiang Liang, Yang Li, Wei Quan, Liang Ouyang, Jifa Zhang · 2025 · Acta Pharmaceutica Sinica B
42. Design, Synthesis, and biological evaluation of HDAC6 inhibitors based on Cap modification strategy
    Xuedong Li, Xingang Liu, Songsong Wang, Xiaoxing Shi, Ming Lü, Xinyue Hao, Yan Fu, Yang Zhang, Qingzhong Jia, Dian He · 2022 · Bioorganic Chemistry
43. HDAC6 inhibitor ACY-1083 shows lung epithelial protective features in COPD
    Jenny Horndahl, Rebecka Svärd, Pia Berntsson, Cecilia Wingren, Jingjing Li, Suado M. Abdillahi, Baishakhi Ghosh, Erin Capodanno, Justin Chan, Lena Ripa et al. · 2022 · PLoS ONE
44. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors
    Amit Kumar, Luni Emdad, Paul B. Fisher, Swadesh Kumar Das · 2023 · Advances in cancer research
45. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases
    Mireia Toledano‐Pinedo, Alicia Porro-Pérez, Linda Schäker‐Hübner, Fernando Romero, Min Dong, Abdelouahid Samadi, Pedro Almendros, Isabel Iriepa, Óscar M. Bautista‐Aguilera, M. Mercedes Rodríguez‐Fernández et al. · 2024 · Journal of Medicinal Chemistry
46. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors
    Maurício T. Tavares, Larissa Costa de Almeida, Thales Kronenberger, Gláucio Monteiro Ferreira, Thainá Fujii de Divitiis, Mônica F. Z. J. Toledo, Neuza Mariko Aymoto Hassimotto, João Agostinho Machado‐Neto, Letícia Veras Costa-Lotufo, Roberto Parise‐Filho · 2021 · Bioorganic & Medicinal Chemistry
47. Constructions of tetrahydro-γ-carboline skeletons via intramolecular oxidative carbon–carbon bond formation of enamines
    Jinglei Lv, Ji Li, Daisy Zhang‐Negrerie, Siyun Shang, Qingzhi Gao, Yunfei Du, Kang Zhao · 2013 · Organic & Biomolecular Chemistry
48. tert‐Butylcarbamate‐Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells
    Sérgio Valente, Daniela Trisciuoglio, Maria Tardugno, Rosaria Benedetti, Donatella Labella, Daniela Secci, Ciro Mercurio, Roberto Boggio, Stefano Tomassi, Salvatore Di Maro et al. · 2013 · ChemMedChem
49. HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue
    Ping Gong, Kun Li, Ying Li, Dan Liu, Linxiang Zhao, Yongkui Jing · 2018 · Cell Death and Disease
50. The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility
    Vanesa Lafarga, Federico Mayor, Petronila Penela · 2012 · Cell Adhesion & Migration
51. HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson's disease
    Khang‐Yen Pham, Shristi Khanal, Ganesh Bohara, Nikesh Rimal, Sang-Hoon Song, Thoa Thi Kim Nguyen, In‐Sun Hong, Jinkyung Cho, Jong-Sun Kang, Sooyeun Lee et al. · 2024 · Redox Biology
52. Calcium signals act through histone deacetylase to mediate pronephric kidney morphogenesis
    Sarah C. Rothschild, Hunter J. Lee, Sarah Ingram, Daniel K. Mohammadi, Gregory S. Walsh, Robert M. Tombes · 2018 · Developmental Dynamics
53. Therapeutic Potential of CKD-504, a Novel Selective Histone Deacetylase 6 Inhibitor, in a Zebrafish Model of Neuromuscular Junction Disorders
    Hui Su Jeong, Hye Jin Kim, Deok‐Ho Kim, Ki Wha Chung, Byung‐Ok Choi, Ji Eun Lee · 2022 · Molecules and Cells
54. Evaluation of functional groups on amino acids in cyclic tetrapeptides in histone deacetylase inhibition
    Md. Shahidul Islam, Mohammed P. I. Bhuiyan, Md. Nurul Islam, Tienabe K. Nsiama, Naoto Oishi, Tamaki Kato, Norikazu Nishino, Akihiro Ito, Minoru Yoshida · 2011 · Amino Acids
55. Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
    Susanna Nencetti, Doretta Cuffaro, Elisa Nuti, Lidia Ciccone, Armando Rossello, Marina Fabbi, Flavio Ballante, Gabriella Ortore, Grazia Carbotti, Francesco Campelli et al. · 2020 · Journal of Enzyme Inhibition and Medicinal Chemistry
56. The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors
    Quaovi H. Sodji, Vishal Patil, Surendra Jain, James R. Kornacki, Milan Mrksich, Babu Lal Tekwani, Adegboyega K. Oyelere · 2014 · Bioorganic & Medicinal Chemistry Letters
57. Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model
    Ting Zhao, Yongqing Li, Baoling Liu, Baihong Pan, Xin Min Cheng, Patrick E. Georgoff, Hasan Badre Alam · 2015 · The Journal of Trauma: Injury, Infection, and Critical Care
58. Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors
    Pradeep S. Jadhavar, Sreekanth A. Ramachandran, Eduardo Riquelme, Ashu Gupta, Kevin P. Quinn, Devleena Shivakumar, Soumya S. Ray, Dnyaneshwar Zende, Anjan K. Nayak, Sandeep K. Miglani et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
59. Silver–copper co-catalyzed cascade intramolecular cyclization/desulfinamide/dehydrogenation: one-pot synthesis of substituted carbazoles
    Yuanqiong Huang, Zhonglin Guo, Hongjian Song, Yuxiu Liu, Qingmin Wang · 2018 · Chemical Communications
60. Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform
    Christopher Blackburn, Cynthia Barrett, Mable Brunson, Janice E. Chin, Dylan B. England, Kris Garcia, Kenneth M. Gigstad, Alexandra E. Gould, Juan A. Gutierrez, Kara M. Hoar et al. · 2014 · Bioorganic & Medicinal Chemistry Letters
61. Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy
    Xiu Quan Gu, Hao Zhang, Min-Ru Jiao, Bo Ram Han, Zixue Zhang, Jianqi Li, Qingwei Zhang · 2021 · European Journal of Medicinal Chemistry
62. Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors
    Gang Liu, Prasenjit Mondal, Na Sang, Zihua Li, Weihua Ding, Liuyue Yang, Yan Liu, Vishal C. Birar, Ashley Gomm, Rudolph E. Tanzi et al. · 2023 · European Journal of Medicinal Chemistry
63. Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents
    Alessandro Papa, Ilaria Cursaro, Luca Pozzetti, Chiara Contri, Martina Cappello, Silvia Pasquini, Gabriele Carullo, Anna Ramunno, Sandra Gemma, Katia Varani et al. · 2023 · Archiv der Pharmazie
64. Histone deacetylase 6 controls cardiac fibrosis and remodelling through the modulation of TGF ‐β1/Smad2/3 signalling in post‐infarction mice
    Junqiao Fang, Shangzhi Shu, Hui Dong, Xueling Yue, Jinshun Piao, Shuyan Li, Lan Hong, Xian Wu Cheng · 2024 · Journal of Cellular and Molecular Medicine
65. Development of second generation epigenetic agents
    PHILIP G. JONES · 2011 · MedChemComm
66. Perfluorinated HDAC inhibitors as selective anticancer agents
    James W. Walton, Jasmine M. Cross, Tina Riedel, Paul J. Dyson · 2017 · Organic & Biomolecular Chemistry
67. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation
    Haoxuan Song, Xueyan Niu, Jishun Quan, Yanchun Li, Lei Yuan, Jian Wang, Chao Ma, Enlong Ma · 2020 · Bioorganic Chemistry
68. Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine–hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer
    Mona M. Abdel-Atty, Nahla A. Farag, Rabah A.T. Serya, Khaled A. M. Abouzid, Samar Mowafy · 2021 · Journal of Enzyme Inhibition and Medicinal Chemistry
69. Antitumor activity of novel POLA1-HDAC11 dual inhibitors
    Sabrina Dallavalle, Loana Musso, Raffaella Cincinelli, Nadine Darwiche, Silvia I. Gervasoni, Giulio Vistoli, Mario Berardino Guglielmi, Ilaria La Porta, Maddalena Pizzulo, Elisa Modica et al. · 2021 · European Journal of Medicinal Chemistry
70. Atrial fibrillation
    Bianca J.J.M. Brundel, Ai, Xun, Hills, Mellanie True, Myrthe F. Kuipers, Gregory Y.H. Lip, Natasja M. S. de Groot · 2016 · Nature Reviews Disease Primers
71. Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells
    Yingjun Li, Yongjun Huang, Huimin Cheng, Fang Lian Xu, Ruxi Qi, Botao Dai, Yujian Yang, Zhengchao Tu, Lijie Peng, Zhang Zhang · 2022 · Frontiers in Chemistry
72. Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation
    Dušan Ružić, Milos Petkovic, Nemanja Djoković, Juan Francisco Santibanez, Bernhard Ellinger, Milan Beljkaš, Sheraz Gul, Ana Djuric, A. Ganesan, Aleksandar Pavić et al. · 2022 · Pharmaceutics
73. Class II histone deacetylases require P/Q-type Ca2+ channels and CaMKII to maintain gamma oscillations in the pedunculopontine nucleus
    Francisco J. Urbano, Verónica Bisagno, Susan Mahaffey, Sang-Hun Lee, Edgar García‐Rill · 2018 · Scientific Reports
74. Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha–induced mitochondrial injury in experimental diabetes
    Shelley L. Baumgardt, Juan Fang, Xuebin Fu, Yanan Liu, Zhengyuan Xia, Ming Zhao, Ling Chen, Rachana Mishra, Muthukumar Gunasekaran, Progyaparamita Saha et al. · 2024 · Cardiovascular Research
75. Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases
    Kairui Yue, Simin Sun, Zequn Yin, Enqiang Liu, Geng Jia, Yuqi Jiang, Yajun Duan, Yuxin Chen, Xiaoyang Li · 2025 · Journal of Medicinal Chemistry
76. Targeting Neuroblastoma Cell Surface Proteins: Recommendations for Homology Modeling of hNET, ALK, and TrkB
    Yazan Haddad, Zbyněk Heger, Vojtěch Adam · 2017 · Frontiers in Molecular Neuroscience
77. Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma
    Shaymaa Emam Kassab, Samar Mowafy, Aya M. Alserw, Joustin A. Seliem, Shahenda El‐Naggar, Nesreen Nabil Omar, Mohamed Medhat Awad · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
78. Exploring structural requirements of isoform selective histone deacetylase inhibitors: a comparative in silico study
    Kriti Kashyap, Rita Kakkar · 2020 · Journal of Biomolecular Structure and Dynamics
79. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344
    Mona Dawood, Edmond Fleischer, Anette Klinger, Gerhard Bringmann, Letian Shan, Thomas Efferth · 2020 · Pharmacological Research
80. HDAC6 contributes to human resistance against Mycobacterium tuberculosis infection via mediating innate immune responses
    Fuzhen Zhang, Shanshan Yu, Qiyao Chai, Jing Wang, Tuoya Wu, Rongmei Liu, Yi Liu, Cui Hua Liu, Yu Pang · 2021 · The FASEB Journal
81. Histone acetylation inhibitors promote axon growth in adult dorsal root ganglia neurons
    Shen Lin, Kutaiba Nazif, Alexander Smith, Peter W. Baas, George M. Smith · 2015 · Journal of Neuroscience Research
82. Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells
    Mona Dawood, Mohamed Elbadawi, Madeleine Böckers, Gerhard Bringmann, Thomas Efferth · 2020 · Biomedicine & Pharmacotherapy
83. HDAC Inhibitors
    Heidi Olzscha, Mina Bekheet, Semira Sheikh, Nicholas Barrie La Thangue · 2016 · Methods in molecular biology
84. Aromatic Ring Fluorination Patterns Modulate Inhibitory Potency of Fluorophenylhydroxamates Complexed with Histone Deacetylase 6
    Paris R. Watson, Ping Bai, Changning Wang, Abigail D. Cragin, Jacob M. Hooker, David W. Christianson · 2022 · Biochemistry
85. Green oxidative rearrangement of indoles using halide catalyst and hydrogen peroxide
    Jian Wang, Yini Chen, Wanting Du, Ningyao Chen, Kang Fu, Qijun He, Liming Shao · 2022 · Tetrahedron
86. Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease
    Ting Liang, Shiru Liu, Baiyun Dang, Xiaofa Luan, Yifan Guo, Raphael R. Steimbach, Jiadong Hu, Long Lu, Peiyu Yue, Ruotian Wang et al. · 2024 · European Journal of Medicinal Chemistry
87. Rationale for HDAC Inhibitor Therapy in Autoimmunity and Transplantation
    Wayne W. Hancock · 2011 · Handbook of experimental pharmacology
88. Exploration of the labeling of [11C]tubastatin A at the hydroxamic acid site with [11C]carbon monoxide
    Shuiyu Lu, Yi Zhang, Jay H. Kalin, Lisheng Cai, Alan P. Kozikowski, Victor William Pike · 2015 · Journal of Labelled Compounds and Radiopharmaceuticals
89. Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile
    Christoph Selg, Andrea Schöler, Julian Schliehe‐Diecks, Maria Hanl, Laura Sinatra, Arndt Borkhardt, Menyhárt B. Sárosi, Sanil Bhatia, Evamarie Hey‐Hawkins, Finn Kristian Hansen · 2021 · Chemical Science
90. Involvement of transcription factor XBP1s in the resistance of HDAC6 inhibitor Tubastatin A to superoxidation via acetylation-mediated proteasomal degradation
    Yue Zhang, Chang‐Mei Liu, Xian-cao Cao, Yi Zang, Yubo Zhou, Jia Xuan Li · 2014 · Biochemical and Biophysical Research Communications
91. Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates
    Vincent Zwick, Alessandra Nurisso, Claudia Avello Simões‐Pires, Samuel Bouchet, Nadine Martinet, Attila Lehotzky, Judit Ovádi, Muriel Cuendet, Christophe Blanquart, Philippe Bertrand · 2015 · Bioorganic & Medicinal Chemistry Letters
92. Overview of Computer-Aided Drug Design for Epigenetic Targets
    Rodrigo Aguayo‐Ortiz, Eli Fernández‐de Gortari · 2016 · Elsevier eBooks
93. Targeting histone deacetylases for heart diseases
    Gang Y Jin, Kaiyue Wang, Yaohui Zhao, Shuo Yuan, Zhangxu He, Jingyu Zhang · 2023 · Bioorganic Chemistry
94. Structure–Activity Relationship of Propargylamine‐Based HDAC Inhibitors
    Matthias Wünsch, Johanna Senger, Philipp Schultheisz, Sabrina Schwarzbich, Karin Schmidtkunz, Carmela Michalek, Michaela Klaß, Stefanie Goskowitz, Philipp Borchert, Lucas Praetorius et al. · 2017 · ChemMedChem
95. Tubastatin A, a deacetylase inhibitor, as a tool to study the division, cell cycle and microtubule cytoskeleton of trypanosomatids
    Jean de Oliveira Santos, Aline Araújo Zuma, Wanderley de Souza, María Cristina M. Motta · 2021 · European Journal of Protistology
96. Design, synthesis, modeling, biological evaluation and photoaffinity labeling studies of novel series of photoreactive benzamide probes for histone deacetylase 2
    Aditya Sudheer Vaidya, Bhargava Karumudi, Emma L. Mendonca, Antonett Madriaga, Hazem Abdelkarim, Richard Bruce van Breemen, Pavel A. Petukhov · 2012 · Bioorganic & Medicinal Chemistry Letters
97. Diagnosis and Therapy of Atrial Fibrillation: The Past, The Present and The Future.
    Denise M.S. van Marion, Eva A.H. Lanters, Marit Wiersma, Maurits A. Allessie, Bianca J.J.M. Brundel, Natasja M. S. de Groot · 2015 · PubMed Central
98. Image-based drug screen identifies HDAC inhibitors as novel Golgi disruptors synergizing with JQ1
    Mathieu Gendarme, Jan Baumann, Tatiana I. Ignashkova, Ralph K. Lindemann, Jan H. Reiling · 2017 · Molecular Biology of the Cell
99. Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma
    Koen Vermeulen, Muneer Ahamed, Kaat Luyten, Guy M Bormans · 2019 · Nuclear Medicine and Biology
100. Epigenetic Drug Discovery for Alzheimer’s Disease
     Ramón Cacabelos, Óscar Teijido · 2017 · Elsevier eBooks